Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
METHADONE HYDROCHLORIDE INJECTION, USP
Medication labelWhy this: Advisory · dailymed-prescription
For the treatment of moderate to severe pain not responsive to non-narcotic analgesics. For use in temporary treatment of opioid dependence in patients unable to take oral medication. Outpatient maintenance and outpatient detoxification treatment may be provided only by opioid treatment programs (OTPs) certified by the Federal Substance Abuse and Mental Health Services Administration (SAMHSA) and registered by the Drug Enforcement Administration (DEA). This does not preclude the maintenance treatment of a patient with concurrent opioid addiction who is hospitalized for conditions other than opioid addiction and who requires temporary maintenance during the critical period of hospitalization, or of a patient whose enrollment has been verified in a program which has been certified for maintenance treatment with methadone. NOTE: INJECTABLE METHADONE PRODUCTS ARE NOT APPROVED FOR THE OUTPATIENT TREATMENT OF OPIOID DEPENDENCE. IN THIS PATIENT POPULATION, PARENTERAL METHADONE IS TO BE USED ONLY FOR PATIENTS UNABLE TO TAKE ORAL MEDICATION, SUCH AS HOSPITALIZED PATIENTS.
- generic_name
- methadone hydrochloride
- brand_name
- Methadone, methadone
- product_names
- methadone hydrochloride, Methadone, methadone
- ndc
- 66479-530, 66479-530-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en